🇺🇸 FDA
Drug

paclitaxel

Brand: PACLITAXEL

approved

Quick answer

paclitaxel (PACLITAXEL), is a pharmaceutical active ingredient, associated with Regen BioPharma Inc, with approved status in the US.

Key facts

INN
paclitaxel
Brand
PACLITAXEL
Route
INJECTION
Formulation
INJECTABLE
Originator
Regen BioPharma Inc

Related patents

patent

US 11944617

Concomitant administration of glucocorticoid receptor modulator relacorilant and

Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11285145

Concomitant administration of glucocorticoid receptor modulator relacorilant and

Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8426385

Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and prep

Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 7179588

Assay for the detection of paclitaxel resistant cells in human tumors

Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 6569459

Method of administration of paclitaxel-plasma protein formulation

Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is paclitaxel?

paclitaxel (PACLITAXEL), is a pharmaceutical active ingredient, associated with Regen BioPharma Inc, with approved status in the US.

What is the brand name for paclitaxel?

PACLITAXEL is a marketed brand name for paclitaxel. Check FDA Drugs@FDA for the current US label holder.